The Asia-Pacific pharmaceutical analytical testing outsourcing market is projected to grow at a CAGR of around 9.5% during the forecast period (2021-2027). The rising number of clinical trials in various economies such as India, China, Japan, and others provide a significant opportunity to the pharmaceutical analytical testing outsourcing market in the region. As per the WHO, China accounted for the highest clinical trials around 31.1 thousand between 2015 and 2019. Cohesive government policies will benefit cardiac safety services since the Chinese government has a series of policies to eliminate the pharmaceutical innovation gap between China and other leading countries. These policies include developing the multinational clinical centers, accelerating the approval process of special medicines, sharing clinical data around the globe, and enhancing the protection of clinical data, among others.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-pharmaceutical-analytical-testing-outsourcing-market
Moreover, rising pharmaceutical outsourcing services in emerging economies such as China, India, and others further provide a significant opportunity for the market. The shift of outsourcing pharmaceutical services towards Asia-pacific economies such as China and India from the US further propels the market. The shifts are experienced due to the presence of many skilled contract manufacturers and the presence of inexpensive labor in the Asia-pacific region. Another major factor that is attracting foreign investments in the Indian pharmaceutical sector is the increasing balance of trade in the pharma sector. The investment in the drug and pharmaceuticals sector will significantly shift the focus of pharmaceuticals companies into the Asia-Pacific market that further increase the demand for pharmaceutical analytical testing outsourcing services in the region.
A Full Report of Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-pharmaceutical-analytical-testing-outsourcing-market
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market – Segmentation
By Product type
- API
- Raw Materials
- Finished products
By Services
- Bioanalytical services
- Stability testing
- Drug substance
- Method development & Validation
- Others (Quality Testing)
Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market – Segmentation by Geography
- China
- India
- Japan
- Rest of Asia-Pacific
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)